Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma

<div>A quantitative method to predict the chance of 1-, 3-, and 5-year overall survival for patients diagnosed with LUAD. (a) A nomogram that estimates the likelihood of 1-, 3-, and 5-year overall survival for patients diagnosed with LUAD. (b) Calibration plots of the nomogram used to assess the overall likelihood of survival at 1, 3, and 5 years.</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma 